| Literature DB >> 27990187 |
M Erriu1, F M G Pili1, S Cadoni2, V Garau1.
Abstract
Atrophic glossitis is a condition characterised by absence of filiform or fungiform papillae on the dorsal surface of the tongue. Consequently, the ordinary texture and appearance of the dorsal tongue, determined by papillary protrusion, turns into a soft and smooth aspect. Throughout the years, many factors, both local and systemic, have been associated with atrophic glossitis as the tongue is currently considered to be a mirror of general health. Moreover, various tongue conditions were wrongly diagnosed as atrophic glossitis. Oral involvement can conceal underlying systemic conditions and, in this perspective, the role of clinicians is fundamental. Early recognition of oral signs and symptoms, through a careful examination of oral anatomical structures, plays a crucial role in providing patients with a better prognosis.Entities:
Keywords: Atrophic tongue; Gastrointestinal disease; Infections; Nutritional deficiency; Systemic conditions
Year: 2016 PMID: 27990187 PMCID: PMC5123136 DOI: 10.2174/1874210601610010619
Source DB: PubMed Journal: Open Dent J ISSN: 1874-2106
Literature analysis of articles focused on AG related to nutritional deficiency.
| Year | Author | Methods | Results | Reference |
|---|---|---|---|---|
| 1993 | Drinka | Nutritional status of 20 elderly patients with a normal tongue and 10 subjects with various degree of AG | Their results demonstrated a statistically significant association between AG and deficiency of vitamin E, considered as another nutrient responsible for the development of AG. | [ |
| 2000 | Bøhmer and Mowe | Nutritional status of 416 old people and the resulting lingual alterations. | The correlation between AG and nutritional indices was statistically significant, and related to low levels of haemoglobin, cholesterol, ascorbic acid, serum iron and serum cobalamin. | [ |
| 2012 | Sun | Comparison of blood hemoglobin concentration, iron, cobalamin, folic acid and homocysteine in 176 patient with AG with 176 healthy controls | Their results showed a statistically significant association among AG and low serum concentration of iron, vitamin B12 and haemoglobin. Patients with AG showed high homocysteine levels. | [ |
| 2013 | Sun | Evaluation of the reduction of homocysteine levels in 91 patients with an AG | AG healed through supplementation of different vitamins and iron | [ |
| 2014 | Wu | Comparison of prevalence of AG studying nutritional status of 75 patient with iron-deficiency anemia and of 150 healthy subjects. | Serum concentration of iron, vitamin B12, folic acid and homocysteine was quantified in the blood samples of all cases. Results showed statistically significant differences in the iron and cobalamin concentrations between the two study groups, while no differences were identified for the other two nutrients | [ |
| 2014 | Demir N | Analysis of prevalence of AG in 57 neonatal patients with vitamin B12 deficiency | Determination of a prevalence of AG of 70.17%. The authors concluded that a deficiency of vitamin B12 should be considered in the differential diagnosis of infants who present with skin and mucosal lesions. | [ |
| 2016 | Bao ZX | Analysis of serum zinc levels in 368 patients (of which 54 had an AG). | The mean serum zinc level in the healthy control group was significantly higher than that of the AG group. | [ |
Nutrients associated with the determination of an AG.
| Vitamin B2 | Riboflavin | vegetables, yeast, milk | Factor involved in oxidation-reduction reactions. | Normochromic normocytic anemia |
| Vitamin B3 | Niacin | meat, beer yeast, cereals | It is involved particularly in the DNA repair process, in the production of steroid hormones and is necessary for cellular oxidation-reduction reactions. | Pellagra |
| Vitamin B6 | Pyridoxin | meat, vegetables | It is a cofactor in several enzymatic reactions involving the metabolism of amino acids, glucose and lipids. | Pellagra (indirectly) |
| Vitamin B9 | Folic acid | kidney, liver, green leafy vegetables, legumes, eggs | Its principal biological role is related to the synthesis of DNA and RNA and in the prevention of genetic alterations. | Megaloblastic anemia |
| Vitamin B12 | Cobalamin | meat, milk, eggs | It is involved in the cells metabolism with several functions such as DNA synthesis, regulatory functions of the nervous system or in the amino acid metabolism. | Pernicious anemia |
| Iron | Iron | meat, vegetables | It carries oxygen in the hemoglobin, in the myoglobin and is also involved in several enzymatic reactions. | Iron-deficiency anemia |
| Zinc | Zinc | Animal-sourced foods and some vegetables | It is involved in various biological reactions in the human body, from cell growth to normal immune function to wound healing. | Different physiological alterations |
Drugs that could be related to the development of an atrophic condition of the tongue.
| Drug name | Application | Side effect potentially producing an atrophic tongue | Ref |
|---|---|---|---|
| Metformin | Type 2 diabetes treatment | Vitamin B12 and folic acid deficiency (in association with proton-pump inhibitor) | [ |
| Proton-pump inhibitor (omeoprazole, lansoprazole) | Acid-lowering agent | Vitamin B12 deficiency (in association with metformin) | [ |
| Histamine antagonist | Acid-lowering agents | Vitamin B12 deficiency | [ |
| Isoniazid | Anti-tuberculosis agent | Vitamin B3 and vitamin B6 deficiency | [ |
| Chloramphenicol | Antibiotic | Vitamin B3 deficiency | [ |
| Fluorouracil | Cancer treatment (antimetabolite) | Vitamin B3 deficiency | [ |
| Oral contraceptives | Contraceptive | Vitamin B6 and folic acid deficiency | [ |
| Anticonvulsants (carbamazepine, valproic acid, gabapentin, phenobarbital, phenytoin and primidone) | Treatment of epilepsy and neuropathic pain | Vitamin B6 and folic acid deficiency | [ |
| Cycloserine | Anti-tuberculosis agent | Vitamin B6 deficiency | [ |
| Penicillamine | Immunosuppression to treat rheumatoid arthritis | Vitamin B6 deficiency | [ |
| Hydrocortisone | Immune system suppression | Vitamin B6 deficiency | [ |
| Mercaptopurine | Immunesuppressive agent | Vitamin deficiency | [ |
| Methotrexate | Treatment of cancer and autoimmune diseases | Folic acid deficiency | [ |
| Sulfasalazine | Rheumatoid arthritis treatment | Folic acid deficiency | [ |
| Triamterene | Treatment of hypertension and edema | Folic acid deficiency | [ |
| Chemotherapy | Cancer treatment | Changes of oral microcirculation | [ |
| Bleomycin | Cancer treatment | Tissutal hypoxia | [ |
| Bisphosphonates (alendronate, etidronate and risedronate) | Metastatic prevention, treatment of osteoporosis and arthritis rheumatoid | Xerostomia, alteration of cellular turnover | [ |
| Antidepressants (clomipramine, doxepin) | Tricyclic antidepressants | Xerostomia, anemia (rare) | [ |
| Fluoxetine | Antidepressant | Xerostomia, gastrointestinal disorders | [ |
| Venlafaxine | Antidepressant | Xerostomia, gastrointestinal disorders | [ |
| Fluvoxamine | Treatment of obsessive-compulsive disorder and major depressive disorder | Xerostomia, gastrointestinal disorders | [ |
| Serteraline | Antidepressant | Gastrointestinal disorders determining malabsorption | [ |
| Antibiotics | Antibacterial activity | Candidiasis, gastrointestinal disorders | [ |
| Rivastigmine | Treatment of dementia of the Alzheimer’s type and dementia due to Parkinson's disease. | Gastrointestinal disorders | [ |
| Sulfonamides | Various | Hemolytic anemia | [ |
| Trihexyphenidyl | Antiparkinsonian agent | Xerostomia | [ |
Summary of the different kind of atrophic disease of the tongue.
| Diagnosis | Epidemiology | Aetiology | Symptoms | Treatment |
|---|---|---|---|---|
| Median Rhomboid glossitis | It affects 0.001%-1% of the population | Candida infection | Usually asymptomatic, | Application of antifungal medicaments |
| Geographic tongue/benign migratory glossitis | Prevalence range from 1% to 2.5% | Unknown | Often asymptomatic, sometimes burning sensation | None, if associated with burning mouth syndrome it is possible to apply topical steroid |
| Atrophic glossitis | Incidence between 1.3-9% | Nutritional defiencies or underlying disease | Asymptomatic | Treatment of the systemic disease (if present) and administration of nutritional supplement (see Table |